MarketScreener Editorial Features bluebird bio, Inc.

Equities

BLUE

US09609G1004

Market Closed - Nasdaq 21:30:01 03/05/2024 BST 5-day change 1st Jan Change
0.8998 USD -0.39% Intraday chart for bluebird bio, Inc. -2.49% -34.80%

MarketScreener Editorial Features

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vertex Pharmaceuticals Incorporated :  Vertex and Crispr to market $2.2 million treatment for sickle cell diseaseVertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease December 11, 2023 at 10:47 am
Global markets live:  Valneva, Volkswagen, Uber, Tesla, Apple...Global markets live: Valneva, Volkswagen, Uber, Tesla, Apple... September 19, 2022 at 04:43 pm
Let the countdown beginLet the countdown begin September 19, 2022 at 03:12 pm
MarketScreener's World Press Review :  August 18, 2022MarketScreener's World Press Review : August 18, 2022 August 18, 2022 at 01:17 pm
Global markets live:  General Motors, JP Morgan, Pfizer, Novavax, Ford...Global markets live: General Motors, JP Morgan, Pfizer, Novavax, Ford... December 13, 2021 at 04:16 pm
Today on Wall Street:  Busy week aheadToday on Wall Street: Busy week ahead December 13, 2021 at 02:43 pm
No results for this search